Rinazolin – antiedematous medicine for topical administration at nasal cavity diseases.

Indications

• Acute rhinitis.
• Allergic rhinitis.
• Attacks of non-infectious vasomotorial rhinitis.
• For restoration of a drainage and nasal breath at diseases of adnexal bosoms of a nasal cavity, the eustachitis connected with rhinitis.
• For discharge of hypostasis before diagnostic manipulations in the nasal courses.

Structure

• active ingredient: oxymetazoline;
substance of 0.5 mg contains
• 1 ml of solution hydrochloride oxymetazoline in terms of 100%;
• other components: a benzalkoniya chloride, polyethyleneglycol, sodium dihydrophosphate a dihydrate, dinatrium phosphate dodecahydrate, propylene glycol, povidone, water purified.

Contraindication

• Hypersensitivity to oxymetazoline or any other component of medicine.
• Atrophic rhinitis.
not to apply
• after transfenoidalny hypophysectomy or other surgical interventions with exposure of a meninx.
• At use of inhibitors of a monoaminooxidase (MAO) and during 2 weeks after the treatment termination by MAO inhibitors and at use of other medicines promoting increase in the ABP.
• Increased intraocular pressure, especially at closed-angle glaucoma.
• Severe forms of cardiovascular diseases (for example, coronary heart disease) and arterial hypertension.
• Pheochromocytoma.
• Metabolic violations (for example hyperthyroidism, diabetes).
• prostate Hyperplasia.
• Porphyria.

Side reactions

from nervous system. Very seldom: concern, insomnia, increased fatigue (drowsiness, a sedation), headaches, hallucinations (especially at children).

from a cardiovascular system. Seldom: palpitation, tachycardia, hypertensia. Very seldom: arrhythmia.

from a respiratory system. Often: discomfort in a nose (for example, burning) or dryness mucous a nose, sneezing. Infrequently: after the effect of use of the medicine Rinazolin ends, – feeling of strong congestion of a nose, nasal bleeding. Very seldom: an apnoea at newborns and newborns.

from a musculoskeletal system. Very seldom: spasms (especially at children).

from the immune system. Infrequently: reactions of hypersensitivity (Quincke's disease, rash, itch).

Route of administration

Before use of medicine a bottle needs to be taken in a palm to warm up it to body temperature. Before introduction of medicine it is necessary to clean a nose carefully. When using to hold a bottle vertically, the spray up. Before application to remove a protective cap of a bottle, to place a nozzle tip in the nasal course, the short sharp movement to squeeze a bottle and, having taken out a tip from a nose, to unclench. During injection it is recommended to inhale a little through a nose.

to Adults and children of 6 years – on 1 injection in each nasal course 2–3 times a day. It is not necessary to apply a single dose more than 3 times a day and more than 5-7 days. It is not necessary to apply doses above recommended.

Drug can be reused only in several days.

Feature of application

Use during pregnancy or feeding by a breast

during pregnancy or feeding by a breast to use medicament with extra care. Exceeding the recommended dosage is not allowed.

. Drug should be used during feeding by a breast in case of careful assessment of a ratio self-interest risk. During feeding by a breast it is not necessary to exceed the recommended dosage as the overdose can reduce amount of breast milk at the woman.

by

to children of 6 years.

Ability to influence speed of response at control of motor transport or other mechanisms

After prolonged use of medicine in the doses exceeding recommended cannot exclude the general influence on a cardiovascular system. In such cases the ability to steer the vehicle can decrease.

Overdose

After considerable overdose or accidental intake the following symptoms can arise: a mydriasis, nausea, vomiting, cyanosis, temperature increase, spasms, tachycardia, palpitation, arrhythmia, cardiovascular insufficiency, cardiac arrest, the increased sweating, agitation, spasms, an artery easy, respiratory frustration, pallor, a miosis, a hyposmia, mental disorders.

besides, oppression of functions from central nervous system can arise that is shown by drowsiness, decrease in body temperature, bradycardia, arterial hypotension, an apnoea and possible development of a coma.

Therapeutic measures of overdose: gastric lavage, intake of activated carbon, ventilation of the lungs. At lowering of arterial pressure to apply phentolamine. It is not necessary to accept angiotonic means. If necessary anticonvulsant therapy is shown.

Interaction with other medicines and other types of interactions

increase in arterial.

pressure leg. Therefore it is not necessary to share these medicines.

to Store

in the place protected from light at a temperature not over 25 ºС.

to Store

out of children's reach.